MDVerse drives personalized, precision therapies just-in-time

Pairing next generation software, analytic, and generative AI with next generation tailor-made therapeutics

All patients deserve access to Regenerative Medicine
REGENERATIVE MEDICINE

Regenerative Medicine is using the body's engineered and modified cells to repair, replace, regenerate, and rejuvenate tissues and organs.  The areas of  most active research are cell and gene therapy and stem cells.

Cellular Immunotherapy

Gene Editing

Stem Cells

Tissue Engineering & BioMaterials

Direct T-cell re-programming

Exosome Therapy

Cellular Scaffolds and Matrices

3D Bioprinting

Ongoing Global Clinical Trials in Cell and Gene Therapy

1345

CANCER

174

NEUROLOGICAL

172

DIABETES

111

CARDIOVASCULAR

111

RARE DISEASES

77

STROKE

THE PROBLEM

Fewer than 50% of clinical supply leaders have confidence in their ability to supply cell and gene therapy trials.

Login or Register to learn more.

DISRUPTIVE TECHNOLOGIES

We deliver decades of academic promise to clinical reality, just-in-time.

Drug development, iterative formulations, manufacturing, and clinical trials are inextricably linked, with patient inclusion at every step.

MDVerse is the crucial integration of the drug creator, pharma, CDMO, academia, clinical site, and materials ecosystem.

Login or Register to learn more.

Data Exchange Demand Across Entire Ecosytem
Regulations
Commercialization

Login or Register to learn more.

THE MISSION

MDVerse enables the revolution in advanced therapies by leveraging our next-generation software, analytics, and AI/ML with industry best practices to ensure precision therapeutics are delivered within the entire ATMP ecosystem

leadership - medicine & science meets technology
Dr. Dawn Daniel

MD, FAASM, Co-Founder, CEO

Subra Ramesh

Co-Founder, CTO

Dr. Ramona Doyle

MD, MSc, DSc, Board Member/Consultant

Rimmo Jolly

Board Member

    Send us a message







    Follow us on LinkedIn



    MDVerse helps you Bridge the Bench-to-Bedside Gap
    globe